Biotech Research

Found 2,508 articles

• Feinstein Institutes Leader Calls for a Federally-Funded, National Maternal Health Moonshot

  12/22/2023

  The United States has the highest maternal mortality rate among developed nations – with worse health outcomes for Black women and other minority groups.

• Feinstein Institutes’ Dr. Christina Brennan honored with Clinical Trials Lifetime Achievement Award

  12/20/2023

  Northwell Health and the Feinstein Institutes for Medical Research’s Christina Brennan, MD, senior vice president of clinical research, has received the Clinical Trial Europe’s Christine Pierre Clinical Trials Lifetime Achievement Award for her dedication to leading innovative, equitable and clinically meaningful clinical trials throughout her career and particularly her leadership in rolling out some of the first national COVID-19 clinical trials in 2020.

• BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research

  12/19/2023

  BioMed X announced a new joint research project with Ono Pharmaceutical Co., Ltd, marking the start of the collaboration between the German biomedical research institute and one of the largest pharmaceutical companies in Japan.

• Feinstein Institutes, Molecular Medicine award Dr. Peter Hotez with 2023 Cerami Award

  12/14/2023

  The Feinstein Institutes for Medical Research and Molecular Medicine announced that Peter Hotez, MD, PhD, a distinguished immunologist, pediatrician, and global health advocate, has been awarded the Anthony Cerami Award in Translational Medicine for his outstanding contributions to the field of molecular medicine and his dedication to addressing global health challenges.

• City of Hope Doctors and Scientists Present Innovative Research at Largest Gathering on Breast Cancer Research

  12/8/2023

  City of Hope, one of the largest cancer research and treatment organizations in the United States, will present innovative research at this year’s San Antonio Breast Cancer Symposium, taking place Dec. 5 to 9 in San Antonio, Texas.

• Sarah Cannon Research Institute to Present Latest Research Insights at the 2023 ASH Annual Meeting & Exposition

  12/7/2023

  Sarah Cannon Research Institute announced that more than 80 abstracts and presentations have been selected for inclusion at the 65th American Society of Hematology Annual Meeting & Exposition.

• Metabolon Wins National Institute of Health (NIH) Award to Develop Test to Improve Polycystic Ovary Syndrome (PCOS) Diagnostic Accuracy

  12/5/2023

  Metabolon, Inc. announced receipt of a National Institute of Health award to improve the accuracy by which polycystic ovary syndrome can be diagnosed.

• Cancer Research UK and Guardant Health Launch Collaboration to Advance Cancer Research and Clinical Development Activities

  12/4/2023

  Cancer Research UK, one of the world’s largest charitable funders of cancer research, its innovation unit, Cancer Research Horizons, and Guardant Health, Inc., a leading precision oncology company, announced a collaboration to explore the sharing of technologies, data, and insights to advance the development and precision of cancer detection and treatment.

• 

  New Initiatives Pump Money into Cell and Gene Therapy Development in New York

  11/16/2023

  The Empire State is seeing large infusions of funds from the state and the Chan Zuckerberg Initiative to develop therapies for cancer and other applications.

• Gradalis Awarded $9.9 Million Grant From the Cancer Prevention and Research Institute of Texas

  11/16/2023

  Gradalis, Inc. announced that it has been awarded a $9.9 million Product Development Research grant from the Cancer Prevention and Research Institute of Texas.

• The Mark Foundation for Cancer Research Accelerates Commitment to Stimulate Innovation With 16 New ASPIRE Awards Totaling Over $5 Million

  11/15/2023

  The Mark Foundation for Cancer Research announced 16 outstanding projects in its latest class of ASPIRE awards, granting more than $5 million for research that aims to answer key feasibility and proof-of-concept questions in an accelerated time frame, and scaling for impact based upon initial success.

• University of Basel Delivers First Biological Implants for Treatment of Cartilage Lesions and Osteoarthritis in Humans

  11/15/2023

  The Department of Biomedicine at the University of Basel and the University Hospital Basel, announced that it delivered the first surgical procedure to treat Osteoarthritis in humans.

• MRES: M2Bio Sciences Marks Milestone Expansion with Launch of Los Angeles Office

  11/14/2023

  Institute of Biomedical Research Corp., a vanguard entity at the forefront of nutraceutical biotechnology specializing in alternative plant-based cannabinoids, medical psilocybin, and cutting-edge mental health therapeutic research driven by artificial intelligence, is pleased to provide the following update:

• WPI Researcher Leads Project To Develop Oxygen Sensor for Premature Infants of Color

  11/14/2023

  The National Institutes of Health has awarded $1.1 million to a team led by Worcester Polytechnic Institute researcher Ulkuhan Guler to develop a first-of-its-kind wearable sensor for premature infants that will address racial bias in healthcare by monitoring oxygen levels two different ways and correcting the measurements to account for variations in skin color.

• BioVAT-HF Phase 1/2 Reveals First Evidence for Effective Heart Repair in Advanced Heart Failure

  11/14/2023

  Repairon together with the University Medical Center Göttingen and Lübeck as well as the German Center for Cardiovascular Research, announced that its Co-Founder Professor Wolfram Zimmermann held a Featured Science presentation at the American Heart Association Scientific Sessions 2023 on November 12, 2023, in Philadelphia, US.

• Karmanos Cancer Institute first to receive new FDA-approved treatment for advanced liver cancer

  11/13/2023

  Karmanos Cancer Institute, the largest provider of cancer care and research in Michigan and part of McLaren Health Care, announced that it will be the first provider in the country to offer patients the new FDA-approved TheraBionic P1 device for the treatment of advanced hepatocellular carcinoma, the most common type of liver cancer.

• Andelyn Biosciences and The Ohio State University Collaborate for Pre-clinical and GMP Manufacturing of Novel Gene Therapies

  11/9/2023

  Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization, is collaborating with The Ohio State University Gene Therapy Institute for the development and clinical manufacturing of novel gene therapies.

• invIOs and Dana-Farber Cancer Institute start collaboration to study novel small molecule INV501 for treatment of glioblastoma

  11/9/2023

  invIOs GmbH, a privately held biotechnology company developing novel therapies for cancer, and Dana-Farber Cancer Institute have entered into a preclinical research collaboration to evaluate invIOs’ small molecule INV501 as a potential treatment for glioblastoma.

• Genetics of Nearby Healthy Tissue May Help Catch Lung Cancer's Return

  11/8/2023

  Genetic information collected from seemingly healthy tissue near lung tumors may be a better predictor of whether cancer will come back after treatment than analysis of the tumors themselves, according to new research led by NYU Langone Health and its Perlmutter Cancer Center.

• BioMed X Launches a New Call for Application in Autoimmune Disease Research

  11/7/2023

  BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology.